Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RANI compared with NKTX: revenue, margins and what each company keeps, and the suppliers and customers both name
RANI
Rani Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
NKTX
Nkarta, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RANI
Rani Therapeutics Holdings, Inc.
vs
NKTX
Nkarta, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
RANI
Rani Therapeutics Holdings, Inc.
Change
0.56
· pre 0.54
· delayed
Mkt cap
$77.5M
Revenue
$2M
Q2 FY26
NKTX
Nkarta, Inc.
Change
1.54
· pre 1.50
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$109.6M
Revenue
—
vs
Compare
Pre-market
Nov 4 '26
delayed
RANI
Rani Therapeutics Holdings, Inc.
vs
NKTX
Nkarta, Inc.
0.56
pre 0.54
delayed
Price
1.54
pre 1.50
delayed
$77.5M
Mkt cap
$109.6M
Q2 FY26
$2M
Revenue
—
Change
Change
RANI
0.56
vs
NKTX
1.54
Pre-market
Nov 4 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RANI: latest quarter is a loss; flow not drawable. NKTX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RANI, solid
NKTX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RANI
6
—
Celltrion
unlisted
supplier
—
Chugai Pharmaceutical
unlisted
supplier
—
ProGen
unlisted
supplier
—
ICL
unlisted
supplier
2 more · RANI chain
›
Shared
0
No disclosed counterparties: NKTX.
Only NKTX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR